Mitochondria in heart failure
- PMID: 20668004
- PMCID: PMC3025720
- DOI: 10.1093/cvr/cvq240
Mitochondria in heart failure
Abstract
This review focuses on the evidence accumulated in humans and animal models to the effect that mitochondria are key players in the progression of heart failure (HF). Mitochondria are the primary source of energy in the form of adenosine triphosphate that fuels the contractile apparatus, and are thus essential for the pumping activity of the heart. We evaluate changes in mitochondrial morphology and alterations in the main components of mitochondrial energetics, such as substrate utilization and oxidative phosphorylation coupled with the level of respirasomes, in the context of their contribution to the chronic energy deficit and mechanical dysfunction in HF.
Figures

Similar articles
-
Mitochondrial dysfunction in heart failure.Heart Fail Rev. 2013 Sep;18(5):607-22. doi: 10.1007/s10741-012-9340-0. Heart Fail Rev. 2013. PMID: 22948484 Free PMC article. Review.
-
Mechanisms of disease: is mitochondrial function altered in heart failure?Methodist Debakey Cardiovasc J. 2013 Jan-Mar;9(1):44-8. doi: 10.14797/mdcj-9-1-44. Methodist Debakey Cardiovasc J. 2013. PMID: 23519321 Free PMC article. Review.
-
Heart failure: is there an energy deficit contributing to contractile dysfunction?Basic Res Cardiol. 1998 Feb;93(1):1-10. doi: 10.1007/s003950050055. Basic Res Cardiol. 1998. PMID: 9538931 Review.
-
Role of YAP/TAZ in Energy Metabolism in the Heart.J Cardiovasc Pharmacol. 2019 Dec;74(6):483-490. doi: 10.1097/FJC.0000000000000736. J Cardiovasc Pharmacol. 2019. PMID: 31815864 Free PMC article. Review.
-
New aspects of impaired mitochondrial function in heart failure.J Bioenerg Biomembr. 2009 Apr;41(2):107-12. doi: 10.1007/s10863-009-9215-9. J Bioenerg Biomembr. 2009. PMID: 19347572 Review.
Cited by
-
Hotspot and Frontier Analysis of Exercise Training Therapy for Heart Failure Complicated With Depression Based on Web of Science Database and Big Data Analysis.Front Cardiovasc Med. 2021 May 19;8:665993. doi: 10.3389/fcvm.2021.665993. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34095256 Free PMC article.
-
Mitochondrial dysfunction in uremic cardiomyopathy.Am J Physiol Renal Physiol. 2015 Mar 15;308(6):F579-87. doi: 10.1152/ajprenal.00442.2014. Epub 2015 Jan 13. Am J Physiol Renal Physiol. 2015. PMID: 25587120 Free PMC article.
-
Metabolic shifts during aging and pathology.Compr Physiol. 2015 Apr;5(2):667-86. doi: 10.1002/cphy.c140041. Compr Physiol. 2015. PMID: 25880509 Free PMC article. Review.
-
Sodium-glucose Cotransporter 2 Inhibitors and Pathological Myocardial Hypertrophy.Curr Drug Targets. 2023;24(13):1009-1022. doi: 10.2174/1389450124666230907115831. Curr Drug Targets. 2023. PMID: 37691190 Free PMC article.
-
Acute inhibition of excessive mitochondrial fission after myocardial infarction prevents long-term cardiac dysfunction.J Am Heart Assoc. 2013 Oct 8;2(5):e000461. doi: 10.1161/JAHA.113.000461. J Am Heart Assoc. 2013. PMID: 24103571 Free PMC article.
References
-
- McMurray JJ, Pfeffer MA. Heart failure. Lancet. 2005;365:1877–1889. doi:10.1016/S0140-6736(05)66621-4. - DOI - PubMed
-
- Neubauer S. The failing heart—an engine out of fuel. NEJM. 2007;356:1140–1151. doi:10.1056/NEJMra063052. - DOI - PubMed
-
- Ashrafian H, Frenneaux MP. Metabolic modulation in heart failure: the coming of age. Cardiovasc Drug Ther. 2007;21:5–7. doi:10.1007/s10557-007-6000-z. - DOI - PubMed
-
- Sanbe A, Tanonaka K, Kobayasi R, Takeo S. Effects of long-term therapy with ACE inhibitors, captopril, enalapril and trandolapril, on myocardial energy metabolism in rats with heart failure following myocardial infarction. J Mol Cell Cardiol. 1995;27:2209–2222. doi:10.1016/S0022-2828(95)91551-6. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous